Filing Details

Accession Number:
0001179110-15-012431
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-08-20 17:34:41
Reporting Period:
2015-08-19
Filing Date:
2015-08-20
Accepted Time:
2015-08-20 17:34:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1600132 Bellerophon Therapeutics Inc. BLPH Pharmaceutical Preparations (2834) 473116175
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1500241 M Jonathan Peacock C/O Bellerophon Therapeutics, Inc.
53 Frontage Road, Suite 301
Hampton NJ 08827
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-08-19 5,000 $5.48 31,427 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported represents the weighted average sales price of shares purchased in multiple transactions at prices ranging from $5.30 to $5.59 per share. The reporting person hereby undertakes upon the request of the Staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.